134 related articles for article (PubMed ID: 2441602)
1. Preeclampsia, delivery, and the hemostatic system.
Saleh AA; Bottoms SF; Welch RA; Ali AM; Mariona FG; Mammen EF
Am J Obstet Gynecol; 1987 Aug; 157(2):331-6. PubMed ID: 2441602
[TBL] [Abstract][Full Text] [Related]
2. Hemostasis in hypertensive disorders of pregnancy.
Saleh AA; Bottoms SF; Norman G; Farag A; Mammen EF
Obstet Gynecol; 1988 May; 71(5):719-22. PubMed ID: 2451798
[TBL] [Abstract][Full Text] [Related]
3. Changes of plasma protease inhibitors in late pregnancy, during delivery and puerperium in normal women and in preeclampsia.
Gamba G; Grignani G; Comerio D; Riccardi A; Bergamaschi P
Ric Clin Lab; 1984; 14(3):521-5. PubMed ID: 6522962
[No Abstract] [Full Text] [Related]
4. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease].
Chavarría Olarte ME; González Gleason A; Lara González AL; Sojo Aranda I; García Paleta Y; Vital Reyes VS; Reyes Fuentes A
Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945
[TBL] [Abstract][Full Text] [Related]
5. Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.
Hayakawa M; Maki M
Gynecol Obstet Invest; 1988; 26(3):181-90. PubMed ID: 3240888
[TBL] [Abstract][Full Text] [Related]
6. Clotting inhibitors and fibronectin as potential markers in preeclampsia.
Paternoster D; Stella A; Simioni P; Trovò S; Plebani P; Girolami A
Int J Gynaecol Obstet; 1994 Dec; 47(3):215-21. PubMed ID: 7705525
[TBL] [Abstract][Full Text] [Related]
7. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.
Kobayashi T; Tokunaga N; Sugimura M; Suzuki K; Kanayama N; Nishiguchi T; Terao T
Semin Thromb Hemost; 1999; 25(5):451-4. PubMed ID: 10625201
[TBL] [Abstract][Full Text] [Related]
8. Low antithrombin III and high plasma fibronectin in pre-eclampsia.
Graninger W; Tatra G; Pirich K; Nasr F
Eur J Obstet Gynecol Reprod Biol; 1985 Apr; 19(4):223-9. PubMed ID: 4007230
[TBL] [Abstract][Full Text] [Related]
9. The value of antithrombin-III and fibronectin in hypertensive disorders of pregnancy.
Sen C; Madazh R; Kavuzlu C; Ocak V; Tolun N
J Perinat Med; 1994; 22(1):29-38. PubMed ID: 8035292
[TBL] [Abstract][Full Text] [Related]
10. Changes in hemostasis activity during delivery and the immediate postpartum period.
Gerbasi FR; Bottoms S; Farag A; Mammen EF
Am J Obstet Gynecol; 1990 May; 162(5):1158-63. PubMed ID: 2140236
[TBL] [Abstract][Full Text] [Related]
11. Markers for endothelial injury, clotting and platelet activation in preeclampsia.
Saleh AA; Bottoms SF; Farag AM; Dombrowski MP; Welch RA; Norman G; Mammen EF
Arch Gynecol Obstet; 1992; 251(3):105-10. PubMed ID: 1605673
[TBL] [Abstract][Full Text] [Related]
12. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia.
Deng L; Bremme K; Hansson LO; Blombäck M
Obstet Gynecol; 1994 Dec; 84(6):941-5. PubMed ID: 7970473
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin levels in pregnancy and puerperium.
Micheli M; De Franco A; Nitti M; Siro-Brigiani G; Lucisano F; Gargano G; Greco P; Pietropaolo F
Clin Exp Obstet Gynecol; 1989; 16(2-3):59-60. PubMed ID: 2758666
[TBL] [Abstract][Full Text] [Related]
15. Fetal fibronectin levels are elevated in maternal plasma and amniotic fluid of patients with severe preeclampsia.
Kupferminc MJ; Peaceman AM; Wigton TR; Rehnberg KA; Socol ML
Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 1):649-53. PubMed ID: 7856700
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of plasma alpha 2-plasmin inhibitor activity in obstetrics].
Miura Y
Nihon Ika Daigaku Zasshi; 1986 Jun; 53(3):258-70. PubMed ID: 3734048
[No Abstract] [Full Text] [Related]
17. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy.
Wickström K; Edelstam G; Löwbeer CH; Hansson LO; Siegbahn A
Scand J Clin Lab Invest; 2004; 64(1):31-40. PubMed ID: 15029874
[TBL] [Abstract][Full Text] [Related]
18. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.
Perry KG; Martin JN
Clin Obstet Gynecol; 1992 Jun; 35(2):338-50. PubMed ID: 1638825
[TBL] [Abstract][Full Text] [Related]
19. Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia.
Hayashi M; Numaguchi M; Ohkubo N; Yaoi Y
Am J Med Sci; 1998 Apr; 315(4):251-7. PubMed ID: 9537640
[TBL] [Abstract][Full Text] [Related]
20. Heparin cofactor activity and antithrombin III antigen levels in preeclampsia.
Friedman KD; Borok Z; Owen J
Thromb Res; 1986 Aug; 43(4):409-16. PubMed ID: 3764801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
